Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Intradermal Influenza Vaccine in Adults
NCT00258934Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2005
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of IDflu in influenza, sponsored by Sanofi. Started Sep 2005; status: completed.
02
Drugs
IDflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00258934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258934.